Annovis Bio, Inc. Liquidation Value Calculator
Annovis Bio, Inc.
Current Price: $1.81 (as of 2026-04-24)
Loading calculator data...
Advanced: All 93 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| accounts_payable | ||||
| Accounts Payable Current total AccountsPayableCurrent |
$2.59M | USD | ||
| cash | ||||
| Cash And Cash Equivalents At Carrying Value total CashAndCashEquivalentsAtCarryingValue |
$19.53M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
$19.53M | USD | ||
| current_liabilities | ||||
| Employee Related Liabilities Current total EmployeeRelatedLiabilitiesCurrent |
$426,202 | USD | ||
| liabilities_current | ||||
| Liabilities Current total LiabilitiesCurrent |
$3.64M | USD | ||
| liabilities_total | ||||
| Liabilities total | $4.23M | USD | ||
| shares_outstanding | ||||
| Common Stock Shares Outstanding total CommonStockSharesOutstanding |
27.2M | shares | ||
Unmapped Tags (84)
| Additional Paid In Capital AdditionalPaidInCapital | $180.55M | USD | ||
| Assets Assets | $21.08M | USD | ||
| Cash FDIC Insured Amount CashFDICInsuredAmount | $250,000 | USD | ||
| Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Common Stock Shares Authorized CommonStockSharesAuthorized | $70.00M | shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $27.20M | shares | ||
| Common Stock Value CommonStockValue | $2,719 | USD | ||
| Deferred Tax Assets Gross DeferredTaxAssetsGross | $45.81M | USD | ||
| Deferred Tax Assets Net DeferredTaxAssetsNet | $0 | USD | ||
| Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards | $18.21M | USD | ||
| Deferred Tax Assets Other DeferredTaxAssetsOther | $85,021 | USD | ||
| Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch | $6.82M | USD | ||
| Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance | $45.81M | USD | ||
| Investment Income Interest InvestmentIncomeInterest | $699,061 | USD | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $21.08M | USD | ||
| Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Preferred Stock Shares Authorized PreferredStockSharesAuthorized | $2.00M | shares | ||
| Preferred Stock Shares Issued PreferredStockSharesIssued | $0 | shares | ||
| Preferred Stock Shares Outstanding PreferredStockSharesOutstanding | $0 | shares | ||
| Prepaid Insurance PrepaidInsurance | $16,063 | USD | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-163.70M | USD | ||
| Stockholders Equity StockholdersEquity | $16.85M | USD | ||
| Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount | $8.60M | USD | ||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | $1.80M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | $8.98M | USD | ||
| Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | $4.53M | USD | ||
| Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | $-0 | pure | ||
| Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | $252,715 | USD | ||
| Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable | $284,542 | USD | ||
| Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities | $-530,154 | USD | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | $-1.82M | USD | ||
| Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities | $34.60M | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $-25.62M | USD | ||
| Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised | $1,999 | USD | ||
| Share Based Compensation ShareBasedCompensation | $1.80M | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | $0 | pure | ||
| Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | $528,000 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | $2.06M | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | $12 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | $147,233 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | $220,000 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | $2 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | $777,000 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | $2.39M | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | $11 | USD/shares | ||
| Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | $0 | USD/shares | ||
| Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | $8 | USD/shares | ||
| Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | $2 | USD/shares | ||
| Earnings Per Share Basic EarningsPerShareBasic | $-1 | USD/shares | ||
| Earnings Per Share Diluted EarningsPerShareDiluted | $-1 | USD/shares | ||
| Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations | $0 | pure | ||
| Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | $0 | pure | ||
| Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | $-0 | pure | ||
| Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | $0 | pure | ||
| Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | $0 | pure | ||
| Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | $0 | pure | ||
| Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations | $0 | USD | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $4.48M | USD | ||
| Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued | $0 | USD | ||
| Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense | $0 | USD | ||
| Income Tax Expense Benefit IncomeTaxExpenseBenefit | $0 | USD | ||
| Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | $7.46M | USD | ||
| Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | $-6.06M | USD | ||
| Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther | $1,581 | USD | ||
| Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes | $0 | USD | ||
| Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch | $1.63M | USD | ||
| Net Income Loss NetIncomeLoss | $-28.85M | USD | ||
| Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted | $-28.85M | USD | ||
| Nonoperating Income Expense NonoperatingIncomeExpense | $841,061 | USD | ||
| Operating Expenses OperatingExpenses | $29.70M | USD | ||
| Operating Income Loss OperatingIncomeLoss | $-29.70M | USD | ||
| Operating Lease Expense OperatingLeaseExpense | $100,000 | USD | ||
| Other Prepaid Expense Current OtherPrepaidExpenseCurrent | $321,009 | USD | ||
| Research And Development Expense ResearchAndDevelopmentExpense | $25.22M | USD | ||
| Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax | $0 | USD | ||
| State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations | $0 | USD | ||
| Accrued Professional Fees Current AccruedProfessionalFeesCurrent | $334,713 | USD | ||
| Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants | $-142,000 | USD | ||
| Number Of Operating Segments NumberOfOperatingSegments | $1 | segment | ||
| Number Of Reportable Segments NumberOfReportableSegments | $1 | segment | ||
| Profit Loss ProfitLoss | $-28.85M | USD | ||
| Security Deposit SecurityDeposit | $7,495 | USD | ||
| Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised | $14,284 | shares | ||
| Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised | $1,999 | USD |
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.